Werewolf Therapeutics Inc... (HOWL)
NASDAQ: HOWL
· Real-Time Price · USD
1.76
0.09 (5.39%)
At close: Oct 15, 2025, 3:59 PM
1.73
-1.70%
After-hours: Oct 15, 2025, 07:57 PM EDT
Werewolf Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
Revenue | 1.89M | 19.94M | 16.4M | n/a |
Cost of Revenue | 1.81M | 1.76M | 2.51M | 735K |
Gross Profit | 71K | 18.18M | 13.89M | -735K |
Operating Income | -73.59M | -40.5M | -56.06M | -50.09M |
Interest Income | 6.67M | 7.42M | 1.91M | 104K |
Pretax Income | -70.52M | -37.37M | -53.81M | -49.98M |
Net Income | -70.52M | -37.37M | -53.81M | -49.77M |
Selling & General & Admin | 19.05M | 18.67M | 21.5M | 14.82M |
Research & Development | 56.43M | 41.78M | 53.76M | 35.27M |
Other Expenses | -1.81M | -1.76M | -5.32M | -735K |
Operating Expenses | 73.67M | 58.68M | 69.95M | 49.35M |
Interest Expense | 4.66M | 3.14M | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | 4.17M | n/a |
Cost & Expenses | 75.48M | 60.45M | 72.46M | 50.09M |
Income Tax Expense | n/a | n/a | n/a | -216K |
Shares Outstanding (Basic) | 43.33M | 35.65M | 28.86M | 27.31M |
Shares Outstanding (Diluted) | 43.86M | 35.65M | 28.86M | 27.31M |
EPS (Basic) | -1.63 | -1.05 | -1.86 | -7.39 |
EPS (Diluted) | -1.63 | -1.05 | -1.86 | -7.39 |
EBITDA | -64.05M | -32.47M | -51.3M | -49.25M |
EBIT | -65.86M | -34.23M | -53.81M | -49.98M |
Depreciation & Amortization | 1.81M | 1.76M | 2.51M | 735K |
Source: Financial Modeling Prep. Financial Sources.